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Original article
Hypertension is a leading attributable risk factor for cardio-
vascular disease (CVD) and kidney disease, and premature 
death globally.1 Evidence from epidemiological studies and 
clinical trials have clearly demonstrated that the risk of blood 
pressure (BP) with adverse CVD outcomes is continuous, 
and more pronounced at higher levels of BP. Fortunately, 
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BACKGROUND
Uncontrolled blood pressure (BP) is a leading risk factor for death and 
disability in South Asia. We aimed to determine the cross-country vari-
ation, and the factors associated with uncontrolled BP among adults 
treated for hypertension in rural South Asia.
METHODS
We enrolled 1,718 individuals aged ≥40  years treated for hyperten-
sion in a cross-sectional study from rural communities in Bangladesh, 
Pakistan, and Sri Lanka. Multivariable logistic regression model was 
used to determine the factors associated with uncontrolled BP (systolic 
BP ≥140 mmHg or diastolic BP ≥90 mmHg).
RESULTS
Among hypertensive individuals, 58.0% (95% confidence interval 
(CI) 55.7, 60.4) had uncontrolled BP: 52.8% (49.0, 56.6) in Bangladesh, 
70.6% (65.7, 75.1) in Pakistan, and 56.5% (52.7, 60.1) in Sri Lanka. The 
odds (odds ratio (95% CI)) of uncontrolled BP were significantly higher 
in individuals with lower wealth index (1.17 (1.02, 1.35)); single vs. 
married (1.46 (1.10, 1.93)); higher log urine albumin-to-creatinine ratio 
(1.41 (1.24, 1.60)); lower estimated glomerular filtration rate (1.23 (1.01, 
1.49)); low vs. high adherence to antihypertensive medication (1.50 
(1.16, 1.94)); and Pakistan (2.91 (1.60, 5.28)) vs. Sri Lanka. However, the 
odds were lower in those with vs. without self-reported kidney disease 
(0.51 (0.28, 0.91)); and receiving vs. not receiving statins (0.62 (0.44, 
0.87)).
CONCLUSIONS
The majority of individuals with treated hypertension have uncon-
trolled BP in rural Bangladesh, Pakistan, and Sri Lanka with significant 
disparities among and within countries. Urgent public health efforts are 
needed to improve access and adherence to antihypertensive medica-
tions in disadvantaged populations in rural South Asia.
Keywords: adherence; antihypertensive medications; blood pressure; 
cardiovascular risk; hypertension.
doi:10.1093/ajh/hpy071
Correspondence: Tazeen H. Jafar (tazeen.jafar@duke-nus.edu.sg).
Initially submitted February 10, 2018; date of first revision April 13, 2018; 
accepted for publication April 26, 2018; online publication April 26, 2018.
© The Author(s) 2018. Published by Oxford University Press on 
behalf of American Journal of Hypertension, Ltd.
1Program in Health Services & Systems Research, Duke-NUS Medical 
School, Singapore;  2Duke Global Health Institute, Duke University, 
Durham, North Carolina, USA;  3Biostatistics, Singapore Clinical Research 
Institute, Singapore;  4Centre for Quantitative Medicine, Duke-NUS 
Medical School, Singapore;  5Tampere Center for Child Health Research, 
University of Tampere and Tampere University Hospital, Tampere, 
Finland;  6Department of Community Health Sciences, Aga Khan 
University, Karachi, Pakistan;  7International Centre for Diarrhoeal 
Disease Research, Dhaka, Bangladesh;  8Clinical Trials Unit, Department 
of Pharmacology, Faculty of Medicine, University of Kelaniya, Kelaniya, 
Sri Lanka;  9School of Kinesiology and Health Science, Faculty of Health, 
York University, Toronto, Ontario, Canada.  
*These three authors contributed equally to data from the respective 
countries.
This is an Open Access article distributed under the terms of the 
Creative Commons Attribution License (http://creativecommons.
org/licenses/by/4.0/), which permits unrestricted reuse, 
distribution, and reproduction in any medium, provided the 
original work is properly cited.
1206 American Journal of Hypertension 31(11) November 2018
Jafar et al.
lowering BP reduces this risk. Currently, over 1.1 billion peo-
ple are affected with hypertension globally, and this number 
is expected to increase to more than 1.5 billion by 2025.2 The 
rise in the number of people with hypertension is projected 
to be particularly steep in South Asia where population has 
shown to be at high risk, trends in age-standardized BP 
levels over the past 4 decades show persistent rise, and the 
prevalence of hypertension is already 40%.2–4
Unfortunately, a significant proportion of the popula-
tion with hypertension is unaware and untreated in South 
Asian countries. However, BP control rates are grossly inad-
equate (<30% controlled to <140/90  mm Hg) even among 
those diagnosed and treated for hypertension. Studies done 
elsewhere show several barriers to hypertension control at 
the individual, community, as well as health systems levels 
including lack of adherence to antihypertensive medications, 
and insufficient medication intensification5–7 Most of South 
Asia is still rural (73% Bangladesh, 64% Pakistan, 71% India, 
85% Sri Lanka) where the population, healthcare infrastruc-
ture and healthcare provider characteristics are very different 
compared to the urban setting.8 Furthermore, the impact of 
poor BP control is expected to be much worse in rural areas 
where CVD case fatality rates have shown to be higher than 
in urban areas.9 However, there is scarcity of information on 
factors potentially responsible for uncontrolled BP among 
treated hypertensives in South Asia. This information is essen-
tial to focus national attention on comprehensive and effective 
public-health action on hypertension control strategies.
We analyzed data on 1,718 individuals aged 40 years or 
older treated for hypertension from rural communities 
of Bangladesh, Pakistan, and Sri Lanka with the following 
objectives:
(1)  To determine the cross-country variation in the pro-
portion of individuals with uncontrolled BP among 
adults with treated hypertension;
(2)  To evaluate the association between the sociode-
mographic factors, lifestyle, comorbid conditions, 
and adherence to antihypertensive medications with 
uncontrolled BP.
We hypothesized that: (i) there will be cross-country vari-
ation in the proportion of individuals with uncontrolled 
BP; (ii) the cross-country variation in uncontrolled BP will 
not be fully accounted for by differences in lifestyle factors, 
comorbid conditions, or adherence to antihypertensive 
medications.
METHODS
Study design and sampling
This was a cross-sectional study conducted as a part of baseline 
assessments in the ongoing cluster-randomized trial, Control 
of Blood Pressure and Risk Attenuation—rural Bangladesh, 
Pakistan, Sri Lanka (COBRA-BPS), in 30 randomly selected 
communities rural Bangladesh, Pakistan, and Sri Lanka.
The study was conducted in Tangail and Munshigaonj dis-
tricts (population 3.2 million) of Bangladesh; Thatta district 
(population 1.5 million) of Pakistan, and Putlam district 
(population 0.7 million) of Sri Lanka. A cluster was defined 
by 250–300 households as listed in local administration sam-
pling frames. These clusters are grouped in geographically 
contiguous administrative units of 10–15 clusters such that 
each unit is served by a government clinic. For the random 
selection of clusters, a total of 30 administrative units were 
randomly selected from the 3 countries (10 in each) followed 
by a random selection of 1 cluster per unit, stratified by dis-
tance from the government clinic in each administrative unit 
thereby ensuring adequate representation of clusters located 
far from the clinic. More details regarding the trial design 
have been published previously.10
The study was approved by the local ethics review com-
mittees in each of 3 countries, UK and Singapore.
Study participants and screening
The eligibility criteria for COBRA-BPS were age 40 years 
or more, residing in the selected clusters, and having hyper-
tension as defined by either persistently elevated BP (systolic 
BP ≥140 mmHg or diastolic BP ≥90 mmHg) based on the 
mean of the last 2 of 3 measurements on 2 separate days, or 
on currently on antihypertensive medications.
Individuals who were permanently bed-ridden or too 
ill or with advanced medical disease (on dialysis, liver fail-
ure, other systemic disease), pregnant, or mentally compro-
mised, and unable to give informed consent were considered 
ineligible for the study.
All BP assessors successfully completed training ses-
sions on the use of the BP measurement protocol. Passing 
requirements for trained BP assessor consisted of satisfac-
tory performance on a skills test assessing preparation of 
study participants for BP measurement, selection of an 
appropriate cuff size, standard BP measurement techniques, 
and concordant live BP measurements with an instructor 
using a calibrated automated “Omron HEM-7300 Blood 
Pressure Monitor,” which has been validated and recom-
mended by the Association for the Advancement of Medical 
Instrumentation (AAMI), the British Hypertension Society 
(BHS), and the European Society of Hypertension.11
Adults aged 40  years or older residing in households in 
randomly selected clusters were approached to participate in 
the study (maximum 3 times if not available for any reasons). 
Informed consent was obtained before any assessments. 
Those already on antihypertensive medications were con-
sidered to have confirmed “treated hypertension” status, and 
enrolled in the study. More than 1 participants per household 
were enrolled if eligible. Participants were advised to refrain 
from coffee, or tea, cigarette smoking, and vigorous exercise 
for at least 30 minutes prior to their BP assessments.10 Three 
readings of BP were taken, each initiated by research staff 3 
minutes apart using the Omron device. Uncontrolled hyper-
tension was defined as systolic BP ≥140 mmHg or diastolic 
BP ≥90 mmHg based on last 2 of 3 readings among individu-
als receiving antihypertensive medications. The individuals 
not treated with antihypertensive medication with elevated 
BP (systolic BP ≥140  mmHg or diastolic BP ≥90  mmHg) 
were visited again after at least 1 week for re-measurement 
of BP for confirmation of newly diagnosed hypertension sta-
tus. This study primarily reports findings on individuals with 
treated hypertension.
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Assessment and outcomes
Uncontrolled BP was defined as systolic BP ≥140 mmHg 
or diastolic BP ≥90 mmHg, and receiving antihypertensive 
medication. The definition was based on persistent elevated 
measurements obtained from the last 2 of 3 readings.
Information on sociodemographic, anthropometry, diet, 
lifestyle and behavior, comorbidities, use and adherence to 
antihypertensive medications were obtained on enrollment. 
Data collection forms were translated in local languages 
(Bengla, Urdu, Sindhi, Sinhala, and Tamil), that have been 
piloted in a feasibility study.12
The sociodemographic information included age, gen-
der, education status (no formal education, received formal 
education), marital status defined as single (never married/
separated/widowed) or married, and socioeconomic status as 
measured by the international wealth index. The wealth index 
was derived using weights proposed by Smits and Steendijk.13 
It is a weighted sum of indicator variables for available facili-
ties in the house plus a constant term. Facilities include hav-
ing television, refrigerator, phone, car, bicycle, cheap utensils 
(table, chair, water cooker, clock/watch, lamp, and radio), 
expensive utensils (deep freezer, air conditioner, motorbike, 
washing machine, and computer), quality of floor material, 
quality of toilet facility, number of sleeping rooms, accessibil-
ity to electricity, and quality of water source. Higher wealth 
index indicates a better socioeconomic status.
Body mass index (BMI) and waist circumference were 
measured for the anthropometric information. Participants 
were classified as obese/over-weight if they had BMI ≥ 
23.5 kg/m2.14,15
Weekly fruit and vegetable intake were collected using an 
abbreviated food frequency questionnaire.12 Physical activity 
level was assessed using the International Physical Activity 
questionnaire.16 The comorbid conditions included self-
reported heart disease, stroke, diabetes, and kidney disease. 
Fasting blood samples were collected for plasma glucose, 
serum creatinine, lipids (total cholesterol, high-density lipo-
protein (HDL) cholesterol, low-density lipoprotein (LDL) 
cholesterol, triglycerides), estimated glomerular filtration 
rate (eGFR), a morning spot urine sample for sodium, albu-
min, and creatinine. Serum creatinine measurements were 
calibrated to isotope dilution mass spectrometry (IDMS) 
and all laboratories adhered to external international quality 
control procedures.17 Dietary sodium was measured by spot 
urine sodium to creatinine ratio and converted into 24-hour 
urine sodium estimates using the Kawasaki formula.18
Current use of antihypertensive and statin medications 
was collected. Adherence to antihypertensive medica-
tions was assessed by administering the 8-items Morisky 
Medication Adherence scale (MMAS-8).19–22 Participants 
with a score of less than 6 on the scale were considered to 
have a low level of medication adherence, while those with 
a score of 6–7 were considered to be moderately adherent, 
and a score of more than 7 denotes a high level of adherence.
Statistical analysis
Proportion of participants with uncontrolled BP was 
estimated along with corresponding 95% confidence 
interval (CI) for each country and overall including all the 
3 countries. Participant characteristics were presented using 
descriptive statistics and compared between the controlled 
and uncontrolled BP groups using the chi-squared test and 
2-sample independent t-test for categorical and continuous 
variables, respectively. Association between each of the par-
ticipant characteristics and uncontrolled BP was evaluated 
using a separate logistic mixed-effect model (basic model) 
adjusted for age, gender, and country to account for potential 
imbalances in the key demographic and geographic charac-
teristics. The association between the participant character-
istics and uncontrolled BP was then assessed including all 
the participant characteristics in the same logistic regression 
model simultaneously (multivariable model). The multi-
variable model was further evaluated with the addition of 
interaction terms between country and participant charac-
teristics to assess country-specific impact. All continuous 
variables were included as z-score standardized for mean 
and standard deviation (SD) in the models for interpretation 
of corresponding odds ratios in terms of per 1 SD increase 
in the variables. All the models included cluster-specific 
random intercepts to account for within cluster correl-
ation. A  P-value less than 0.05 was considered statistically 
significant.
Sensitivity analysis were conducted to assess the propor-
tion of individuals with uncontrolled BP among those with 
treated hypertension (i) in each country by distance of clus-
ters to the government clinic; (ii) by self-reported chronic 
disease groups defined as self-reported heart diseases or 
stroke or kidney diseases; and (iii) by economic status with 
IWI as a categorical variable (poor: <15 percentile, Middle: 
15–85th percentile, Rich: >85th percentile).
RESULTS
A total of 11,510 individuals aged 40 years or older were 
approached for screening during April 2016 to March 2017: 
4,442 in Bangladesh, 4,760 in Pakistan, 2,308 in Sri Lanka. 
Of these, 895 (20.1%), 894 (18.8%), and 854 (37.0%) were 
hypertensive (treated and newly diagnosed). Supplementary 
Appendix Figure 1 shows cumulative study enrollment from 
all 3 countries. Among those with hypertension (n = 2,643), 
670 (74.9%), 361 (40.4%), and 687 (80.4%) were on treat-
ment with antihypertensive medications in Bangladesh, 
Pakistan, and Sri Lanka, respectively (Table  1). Among 
those with treated hypertension (n = 1,718), 58.0% (95% CI 
55.7–60.3) had uncontrolled BP: 52.8% (95% CI 49.0–56.6) 
in Bangladesh, 70.6% (95% CI 65.7–75.1) in Pakistan, and 
56.5% (95% CI 52.7–60.1) in Sri Lanka.
Figure  1 illustrates the proportion of individuals with 
uncontrolled BP. Of these, 69%, 24%, and 7% were receiv-
ing 1, 2, and 3 or more agents, respectively (for country-wise 
proportions, see Figure 2).
The comparison of sociodemographic, lifestyle, comorbid 
conditions, and adherence to antihypertensive medications 
between individuals with and without uncontrolled BP is 
shown in Table 1. Supplementary Appendix Table 1 shows 
the same comparison for stratified by country.
In the basic models (Table 2, column 2), lower wealth index 
(P = 0.045), being single vs. married (P = 0.007), low vs. high 
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Table 1. Sociodemographic and disease characteristics of those who took antihypertensive medications by hypertension control status
All countries (N = 1,718)
Characteristics
All (N = 1,718, 
100%)
Uncontrolled hypertensive 
patientsa (N = 997, 58.0%)
Controlled hypertensive 
patients (N = 721, 42.0%)
P (uncontrolled vs. 
controlled)
Demographic characteristics
Age (years), Mean (SD) 59.70 (11.51) 59.83 (11.45) 59.50 (11.61) 0.561
Male, n (%) 523 (30.4) 287 (28.8) 236 (32.7) 0.079
Education, n (%) 0.216
 No formal education 591 (34.4) 355 (35.6) 236 (32.7)
 Formal education 1,127 (65.6) 642 (64.4) 485 (67.3)
Currently working, n (%) 421 (24.5) 238 (23.9) 183 (25.4) 0.473
Married, n (%) 1,197 (69.7) 662 (66.4) 535 (74.2) 0.001
Anthropometric characteristics
Obese/overweight (≥23.5 BMI), n (%) 1,014 (59.0) 610 (61.2) 404 (56.0) 0.044
BMI (kg/m2), Mean (SD) 25.02 (4.80) 25.24 (4.88) 24.71 (4.67) 0.028
Waist circumference (cm), Mean (SD) 88.68 (12.69) 89.21 (12.46) 87.95 (12.97) 0.044
Socioeconomic characteristics
International wealth index, Mean (SD) 61.83 (20.25) 61.18 (20.49) 62.73 (19.88) 0.117
Life-style characteristics
Currently smoking, n (%) 115 (6.7) 65 (6.5) 50 (6.9) 0.734
Physical activity level, n (%) 0.026
 Inactive 458 (26.7) 290 (29.1) 168 (23.3)
 Minimally active 974 (56.7) 544 (54.6) 430 (59.6)
 Highly active 286 (16.6) 163 (16.3) 123 (17.1)
Self-reported health characteristics
Chronic diseases related to 
hypertensionb, n (%)
499 (29.0) 250 (25.1) 249 (34.5) <0.001
 Heart disease, n (%) 280 (16.3) 139 (13.9) 141 (19.6) 0.002
 Stroke, n (%) 244 (14.2) 128 (12.8) 116 (16.1) 0.057
 Kidney disease, n (%) 64 (3.7) 33 (3.3) 31 (4.3) 0.285
Diabetes, n (%) 459 (26.7) 274 (27.5) 185 (25.7) 0.399
Morisky adherence level for 
antihypertensive medications, n (%)
<0.001
 Low 709 (41.3) 451 (45.2) 258 (35.8)
 Medium 428 (24.9) 234 (23.5) 194 (26.9)
 High 581 (33.8) 312 (31.3) 269 (37.3)
Number of antihypertensive medications, 
n (%)
0.167
 1 1,152 (67.1) 685 (68.7) 467 (64.8)
 2 446 (26.0) 242 (24.3) 204 (28.3)
 ≥3 120 (7.0) 70 (7.0) 50 (6.9)
Currently on statins, n (%) 324 (18.9) 154 (15.4) 170 (23.6) <0.001
Food-intake and laboratory measures
Vegetables intake (at least once a week), 
n (%)
1,636 (95.2) 952 (95.5) 684 (94.9) 0.553
Fruits intake (at least once a week), n (%) 939 (54.7) 540 (54.2) 399 (55.3) 0.629
24-hour urine sodium (g/day), Mean (SD) 4.71 (1.51) 4.73 (1.53) 4.69 (1.49) 0.674
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adherence to antihypertensive medications (P <0.001), not 
receiving vs. receiving statins (P <0.001), without vs. with 
concomitant self-reported heart disease (P = 0.010), higher 
urine albumin excretion (P < 0.001), higher fasting glucose 
(P < 0.001), lower eGFR (P = 0.040), and higher serum LDL 
cholesterol (P = 0.001) were associated with statistically sig-
nificantly higher odds of uncontrolled BP. Pakistan had sig-
nificantly higher odds of uncontrolled BP compared to Sri 
Lanka (P < 0.001).
As shown in Table 2 column 3, in the multivariable model, 
the odds ratio (95% CI) of factors associated with uncon-
trolled BP were being single vs. married (1.46 (1.10, 1.93)), 
lower wealth index (1.17 (1.02, 1.35)), with vs. without self-
reported kidney disease (0.51 (0.28, 0.91)), low adherence 
(1.50 (1.16, 1.94)), vs. high adherence to antihypertensive 
medications, receiving vs. not receiving statins (0.62 (0.44, 
0.87)), high urine albumin-to-creatinine ratio (1.41 (1.24, 
1.60)), low eGFR (1.23 (1.01, 1.49)) and living in Pakistan 
(2.91 (1.60, 5.28)) vs. Sri Lanka were independently and sig-
nificantly associated with uncontrolled BP.
Statistically significant interactions were observed 
between Pakistan (reference to Sri Lanka) for several par-
ticipant characteristics (education status, obese/overweight, 
waist circumference, fruit intake, HDL cholesterol, and tri-
glycerides) in the multivariable model for uncontrolled BP 
(Supplementary Appendix Table 2). For example, the odds 
ratio of uncontrolled BP for obese/overweight was 3.34 times 
higher in Pakistan compared to Sri Lanka (P = 0.02). Similarly, 
the ratio of odds ratios (ROR) (interaction) for uncon-
trolled BP for every unit higher HDL cholesterol (mg/dl) 
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Figure 1. Proportion (95% confidence interval) of individuals with uncontrolled BP among those with treated hypertension.
All countries (N = 1,718)
Characteristics
All (N = 1,718, 
100%)
Uncontrolled hypertensive 
patientsa (N = 997, 58.0%)
Controlled hypertensive 
patients (N = 721, 42.0%)
P (uncontrolled vs. 
controlled)
Loge urine spot albumin-to-creatinine  
ratio (mg/g), Mean (SD)
2.79 (1.38) 2.95 (1.42) 2.56 (1.29) <0.001
Systolic blood pressure (mmHg),  
Mean (SD)
143.81 (23.31) 158.53 (18.35) 123.46 (10.74) <0.001
Diastolic blood pressure (mmHg),  
Mean (SD)
86.20 (14.80) 94.55 (12.34) 74.67 (9.05) <0.001
Fasting plasma glucose (mg/dl),  
Mean (SD)
116.89 (46.42) 120.73 (52.34) 111.66 (36.25) <0.001
eGFR (ml/minute per 1.73 m2),  
Mean (SD)
70.81 (24.60) 70.95 (24.67) 70.61 (24.52) 0.782
Total cholesterol (mg/dl), Mean (SD) 196.10 (47.48) 199.67 (48.66) 191.23 (45.41) <0.001
HDL cholesterol (mg/dl), Mean (SD) 45.77 (12.97) 46.25 (13.02) 45.13 (12.89) 0.087
LDL cholesterol (mg/dl), Mean (SD) 125.43 (39.74) 127.57 (40.32) 122.53 (38.78) 0.012
Triglycerides (mg/dl), Mean (SD) 151.55 (92.18) 153.28 (91.94) 149.19 (92.53) 0.381
Abbreviations: BMI, body mass index; eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein; 
SD, standard deviation.
aUncontrolled hypertension was defined as systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg. Participant charac-
teristics are defined in the methods section.
bChronic disease related to hypertension were defined as self-reported presence of heart disease, stroke, or kidney disease.
Table 1. Continued
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was 2.07 (P ≤ 0.01) in Pakistan compared to Sri Lanka. 
Bangladesh differed statistically significantly for odds ratio 
of uncontrolled BP from Sri Lanka in education status, urine 
spot albumin-to-creatinine ratio, and adherence of antihy-
pertensive medication., The odds ratio in Bangladesh were 
lower for log urine albumin-to-creatinine ratio (ROR = 0.65; 
P = 0.03), but higher for education (ROR = 3.36; P = 0.02) 
and medium adherence to antihypertensive medica-
tions (ROR  =  1.99; P  =  0.03) compared to Sri Lanka 
(Supplementary Appendix Table 2).
Sensitivity analysis yielded consistent results 
(Supplementary Appendix Tables 3–5).
DISCUSSION
Using a common standardized protocol in 30 rural com-
munities in South Asia, our study found that the majority 
(53%, 71%, and 57%) of individuals with treated hyperten-
sion have uncontrolled BP in Bangladesh, Pakistan, and Sri 
Lanka, respectively, with substantial cross-country vari-
ation. Our findings are unique in demonstrating the inde-
pendent association of low within country wealth index, and 
low adherence to antihypertensive medicines with higher 
odds of uncontrolled BP in this rural region. These find-
ings underscore the urgency for immediate public health 
action to target the identified barriers and enhance access to 
quality hypertension care services especially in the poorest 
of the poor populations living in the rural communities in 
South Asia.
Our findings are broadly consistent with other reports of 
a high proportion of adults with uncontrolled BP is consist-
ent with studies in other low- and middle-income countries 
(LMICs). For example, 2 in 3 individuals on treatment for 
hypertension in 17 LMICs had uncontrolled BP in the PURE 
study.23 Poorer households have been associated with uncon-
trolled BP in India, Saudi Arabia, Malaysia, and Turkey24 
Similar trends with low wealth and uncontrolled BP have 
been observed in Sub-Saharan Africa25 In part, much of the 
relationship between wealth inequalities in disparities in BP 
control is attributed to weak health systems resulting in poor 
access to medications especially in low income countries.24 
Our study extends the literature by concomitantly account-
ing for lifestyle factors, comorbid conditions, and adherence 
to antihypertensive medications in the analysis. We demon-
strate an independent relationship between low wealth index 
and higher odds of uncontrolled BP suggesting that factors 
in addition to health systems account for the observed asso-
ciation. Studies from the United Kingdom show that lower 
social positioning is associated with lower heart rate vari-
ability and autonomic dysfunction predisposing to higher 
BP and metabolic syndrome.26 Our findings highlight that 
the need of comprehensive pro-poor public health programs 
for hypertension management in rural South Asia.27,28
We found that low adherence to antihypertensive ther-
apy was one of the key factors independently associated with 
high odds of uncontrolled BP in all 3 countries. Moreover, 
the majority of individuals in each of the 3 countries were 
receiving one antihypertensive medication only. The situ-
ation is similar in many LMICs. Recently reported China 
PEACE Million Persons Project showed the vast majority 
(81%) with poor BP control (70% of hypertensive popula-
tion) were using one medication only.29 Epidemiological 
evidence from major clinical trials show that it takes 2–3 anti-
hypertensive medications to control BP to <140/90 mmHg.30 
In the United States, the overall hypertension control rate 
increased from 29% in NHANES 2001 to 2002 to 47% in 
NHANES 2009 to 2010. The proportion of patients taking 
multiple classes of antihypertensive medication increased 
from 37% to 48% during this period.31 Taken together, these 
findings indicate lack of effective titration of number of anti-
hypertensive medications is likely to be a major barrier to 
hypertension control in rural South Asia.
Being single compared to married was associated with 
higher odds of uncontrolled BP in the multivariable model. 
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Figure 2. Proportion of individuals according to number of antihypertensive medications.
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Table 2. Factors associated with uncontrolled hypertension in rural Bangladesh, Pakistan, and Sri Lanka
Characteristics
Basic models
Odds ratio (95% CI) (P)
Multivariable model
Odds ratio (95% CI) (p)
Demographic characteristics
Educated (Ref: No formal education) 1.12 (0.86, 1.46) (0.385) 1.16 (0.86, 1.55) (0.335)
Working (Ref: Not working) 1.04 (0.79, 1.38) (0.784) 0.93 (0.68, 1.26) (0.637)
Not married (Ref: Married) 1.41 (1.10, 1.82) (0.007) 1.46 (1.10, 1.93) (0.008)
Anthropometric characteristics
Obese/overweight (Ref: Nonobese) 1.19 (0.96, 1.47) (0.116) 1.11 (0.83, 1.49) (0.495)
Waist circumference (per 1 SD increase) 1.10 (0.99, 1.23) (0.071) 1.07 (0.92, 1.25) (0.397)
Life-style characteristics
Current smoker (Ref: Nonsmoker) 0.99 (0.65, 1.50) (0.948) 1.00 (0.62, 1.59) (0.989)
Physical activity level (Ref: Inactive) (0.527) (0.440)
 Minimally active 0.87 (0.68, 1.11) (0.261) 0.84 (0.64, 1.10) (0.207)
 Highly active 0.92 (0.66, 1.28) (0.618) 0.91 (0.63, 1.30) (0.596)
Food-intake and 24-hrs urine sodium excretion
Vegetables intake at least once per week (Ref: Less than once per week) 1.01 (0.62, 1.63) (0.980) 0.87 (0.52, 1.46) (0.589)
Fruits intake at least once per week (Ref: Less than once per week) 1.00 (0.81, 1.22) (0.983) 0.96 (0.77, 1.21) (0.756)
24-hrs sodium level (per 1 SD increase) 1.02 (0.91, 1.15) (0.675) 1.02 (0.90, 1.15) (0.807)
Socioeconomic characteristic
International wealth index (per 1 SD decrease) 1.13 (1.00, 1.28) (0.045) 1.17 (1.02, 1.35) (0.028)
Self-reported health characteristics
Chronic diseases related to hypertension (Ref.: Not reported) 0.68 (0.54, 0.84) (<0.001) 0.73 (0.57, 0.92) (0.009)
 Heart disease (Ref: Not reported) 0.71 (0.54, 0.92) (0.010) 0.85 (0.63, 1.14) (0.282)
 Stroke (Ref: Not reported) 0.84 (0.63, 1.12) (0.235) 0.88 (0.64, 1.20) (0.405)
 Kidney disease (Ref: Not reported) 0.76 (0.45, 1.28) (0.299) 0.51 (0.28, 0.91) (0.023)
Diabetes (Ref.: Not reported) 1.20 (0.96, 1.51) (0.111) 1.06 (0.79, 1.43) (0.702)
Laboratory parameters
Loge urine spot albumin-to-creatinine ratio (per 1 SD increase) 1.40 (1.24, 1.57) (<0.001) 1.41 (1.24, 1.60) (<0.001)
Fasting plasma glucose level (per 1 SD increase) 1.26 (1.11, 1.42) (<0.001) 1.16 (0.99, 1.35) (0.068)
eGFR (per 1SD decrease) 1.20 (1.01, 1.43) (0.040) 1.23 (1.01, 1.49) (0.040)
HDL cholesterol level (per 1 SD increase) 1.12 (0.97, 1.28) (0.116) 1.04 (0.88, 1.22) (0.672)
LDL cholesterol level (per 1 SD increase) 1.22 (1.09, 1.36) (0.001) 1.14 (1.00, 1.30) (0.058)
Triglycerides level (per 1 SD increase) 1.05 (0.94, 1.17) (0.406) 0.97 (0.86, 1.10) (0.652)
Medication adherence
Adherence level of antihypertensive medications (Ref: High) (<0.001) (0.003)
 Medium 1.08 (0.84, 1.41) (0.544) 1.03 (0.77, 1.36) (0.862)
 Low 1.54 (1.22, 1.95) (<0.001) 1.50 (1.16, 1.94) (0.002)
Currently on statins (Ref: Not currently on statin) 0.52 (0.39, 0.69) (<0.001) 0.62 (0.44, 0.87) (0.005)
Other characteristics
Age (per 1 SD increase) 1.06 (0.96, 1.18) (0.268) 0.92 (0.78, 1.07) (0.275)
Male (Ref: Female) 0.84 (0.68, 1.04) (0.103) 1.06 (0.77, 1.46) (0.736)
Country (Ref: Sri Lanka) (<0.001) (<0.001)
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High family support has also been associated with CVD ben-
efits for both spouses.32 Strategies of engaging family mem-
bers in hypertension management have shown promising 
results in rural China, must be encouraged in South Asia.33
While self-reported kidney disease was associated with 
better BP control, masked comorbidities identified by 
laboratory tests such as higher albuminuria and lower eGFR 
(both markers of kidney damage) were associated with 
higher odds of uncontrolled BP. Findings from the CRIC 
study indicate the majority of patients with CKD require 3 
or more antihypertensive agents to control BP.34 Our find-
ings underscore the importance of screening for CKD, as the 
vast majority are asymptomatic, to risk stratify individuals 
and BP treatment intensification among those with CKD in 
rural South Asian countries.
Finally, we observed that the proportion of individuals 
with uncontrolled BP was higher in Pakistan (about 2 in 
3) than the other 2 countries (about 1 in 2). The number of 
antihypertensive medications used was lowest in Pakistan 
followed by Bangladesh. Unfortunately, there is no universal 
health coverage in Pakistan or Bangladesh, antihypertensive 
medications are not free in both the countries where more 
than 80% of expenditure on medications has been reported 
to be out-of-pocket, while selected generic antihypertensive 
medications based on the country essential medicines list of 
2013 are provided free-of-cost in the public healthcare sec-
tor in Sri Lanka.2 These cross-country comparisons from the 
region highlight the need for reducing disparities in all of 
South Asia by ensuring access to quality antihypertensive 
medications with good coverage.35
Our study has some limitations. First, the clusters (com-
munities) sampled in the 3 countries were not nationally 
representative. However, all communities (clusters) were 
randomly selected from the respective districts in the rural 
areas. Second, the cross-sectional design of the study does 
not establish causality of association with the determinants 
evaluated. However, the identified factors especially offer 
valuable information to be considered in designing targeted 
hypertension control programs. Third, only crude meas-
ures of dietary intake of fruit and vegetables were avail-
able. However, intake of produce is uniformly poor across 
the rural South Asian region including India.36 Fourth, 
MMAS-8 has been not validated in all the dialects of study 
populations. However, the scale underwent careful cycles 
of translation and back-translation, and pretesting prior to 
administration. Moreover, it has been validated in Urdu in 
Pakistan.37 Finally, 24-hour urine sodium was estimated 
from single spot urine sample rather than multiple 24-hour 
samples over several days. However, the latter is impractical 
especially in a field setting, and spot urine sodium has been 
shown to provide a reasonable albeit not perfect snapshot of 
dietary salt intake.18
Major strengths of our study are inclusion of representa-
tive rural community population with door to door sampling 
in 3 countries. The stratification of communities (clusters) 
by distance from government clinics and a minimum dis-
tance (7 kilometers) ensured representation of communities 
near and farther away from clinics in each country thereby 
enhancing the generalizability of findings to most rural areas 
in the 3 countries, and are consistent with other reports of 
poor hypertension control in rural South Asia.24 The stand-
ardized protocols for BP measurements in all 3 countries, 
using AAMI and BHS recommended digital Omron digital 
device, and multiple readings of BP, and use of Morisky scale 
for adherence enhance the validity of our findings. Thus, we 
believe our findings are robust.
It is also important to underscore that Bangladesh, 
Pakistan, and Sri Lanka, each have a government-funded 
community health workers’ (CHW) program embedded in 
their primary health system for basic maternal and child care 
and family planning services.2 However, this cadre of CHW 
does not have the mandate (or training) to provide noncom-
municable disease or hypertension screening or related edu-
cation.38 Our previous work in urban Pakistan suggests that 
a combined strategy of training CHW coupled with training 
providers in updated hypertension management is effective 
and cost-effective in lowering BP.39 The ongoing COBRA-
BPS trial in rural Bangladesh, Pakistan, and Sri Lanka is 
evaluating these interventions with additional components 
including a financing model for integration in the rural pub-
lic health infrastructure.10
In conclusion, our study highlights that the majority of indi-
viduals with hypertension in rural communities in Bangladesh, 
Pakistan, and Sri Lanka have uncontrolled BP, and there are 
cross-country as well as within country disparities in BP con-
trol in the region. The odds for uncontrolled hypertension 
were especially high among individuals residing in Pakistan 
where number of antihypertensive medications used was the 
lowest. In all the 3 countries, the odds of uncontrolled hyper-
tension were higher in individuals who were single vs. married, 
Characteristics
Basic models
Odds ratio (95% CI) (P)
Multivariable model
Odds ratio (95% CI) (p)
 Bangladesh 0.91 (0.62, 1.33) (0.637) 1.00 (0.61, 1.65) (0.994)
 Pakistan 2.11 (1.38, 3.23) (0.001) 2.91 (1.60, 5.28) (<0.001)
Participant characteristics are defined in the methods section. Waist circumference, 24-hour sodium level, wealth index, Log urine spot 
albumin-to-creatinine ratio, fasting plasma glucose level, eGFR, HDL cholesterol level, LDL cholesterol level, triglycerides level, and age are 
presented as z-score standardized for mean and standard deviation.
P-values in bold represent joint-significance of all the categories using the Wald’s test. Each basic model was adjusted for country, age, and 
gender. Detailed description of the basic and multivariable models is provided in the methods section.
Abbreviations: CI, confidence interval; Ref, reference; eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; LDL, 
low-density lipoprotein.
Table 2. Continued
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residing in lower wealth index households, with lower adher-
ence to antihypertensive medications, and in the presence of 
albuminuria or reduced kidney function. Our findings have 
significant public health implications and underscore the 
urgency for prioritizing comprehensive hypertension manage-
ment program in the rural communities in South Asia.
SUPPLEMENTARY MATERIAL
Supplementary data are available at American Journal of 
Hypertension online.
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